Torii Of Japan Develops With Riken Institute Anti Cedar-Pollen Vaccine
This article was originally published in PharmAsia News
Executive Summary
Torii Pharmaceutical - a Japanese drug maker and Riken Institute have partnered to develop a vaccine to prevent an allergy that affects more than a fifth of the country